Latest AstraZeneca News & Updates

See the latest news and media coverage for AstraZeneca. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
AstraZeneca

Science-led biopharmaceutical company

astrazeneca.com
Headquarters
Cambridge, United Kingdom
Company type
Public company
Number of employees
75,000+

Last updated

Latest news about AstraZeneca

In short: AstraZeneca reported record Q1 2026 revenue exceeding $15 billion while advancing major rare disease and oncology pipeline programs and investments.

Company announcements

  • AstraZeneca

    AstraZeneca's Truqap receives FDA ODAC recommendation

    The committee voted 7-1 in favor of Truqap plus abiraterone and ADT for PTEN-deficient mHSPC based on CAPItello-281 trial results showing improved rPFS.

  • AstraZeneca

    AstraZeneca reports FDA ODAC's mixed vote on camizestrant

    The committee voted 3-6 against majority on benefit-risk for camizestrant plus CDK4/6 inhibitor in HR-positive breast cancer with ESR1 mutation. AstraZeneca remains committed and awaits FDA decision.

  • AstraZeneca

    AstraZeneca delivers strong Q1 2026 growth

    Total Revenue exceeds $15 billion. They advance Phase III programmes and stay on track for 2030 ambitions.

  • AstraZeneca

    AstraZeneca reports Q1 2026 results

    Total revenue rises 8% to $15.3bn. Core EPS increases 5% to $2.58. Company reconfirms FY 2026 guidance.

Unlock all announcements with a

Media coverage

  • Lawyerly

    Pharmacor can challenge patent term extension in AstraZeneca case

    "button" data-redirect-url=" data-display-label="0" data-show-count="1" data-bookmark-label="Save" data-bookmarked-label="Saved" data-loggedin="0" data-type="post" data-object_id="369155" class="cbxwpbkmarktrig cbxwpbkmarktrig-button-addto ld-ext-left" title="Bookmark This" href="#">Save (0) Please login to bookmark<a class="cbxwpbkmarkguesttrig_close" role="button" title="Click to close...

  • Pharmaphorum

    Judge knocks back AstraZeneca's IRA challenge

    AstraZeneca's legal challenge to Medicare's drug pricing negotiation powers has stumbled at the first hurdle in a federal court. US judge Colm Connolly of US...

  • Law360

    AstraZeneca Reps Fight To Keep Opt-Ins In Pay Bias Suit - Law360

    Female pharmaceutical sales representatives in an AstraZeneca equal pay suit have urged an Illinois federal court to reject the company's bid to dismiss two dozen...

  • GenomeWeb

    Immunai Expands Collaboration With AstraZeneca in Deal Worth up to $37.5M

    Immune profiling firm Immunai on Thursday announced an expanded collaboration with drugmaker AstraZeneca through which the company could receive up to $37.5 million over 2026...

Unlock all articles with a

Never miss news about AstraZeneca

Track AstraZeneca and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

AstraZeneca competitors & trending companies

Browse news for competitors to AstraZeneca and other trending companies.